- Is Microsatellite Instability Really a Good Prognostic Factor of Colorectal Cancer?
-
Ui Sup Shin, Sang Sik Cho, Sun Mi Moon, Sun Hoo Park, Sun Hee Jee, Eun-Joo Jung, Dae-Yong Hwang
-
Ann Coloproctol. 2014;30(1):28-34. Published online February 28, 2014
-
DOI: https://doi.org/10.3393/ac.2014.30.1.28
-
-
4,977
View
-
43
Download
-
33
Web of Science
-
25
Citations
-
Abstract
PDF
- Purpose
The aim of this study was to investigate the clinicopathologic features of and the prognosis for colorectal cancers (CRCs) with microsatellite instabilities (MSIs). MethodsBetween 2006 and 2009, genotyping was performed on 245 patients with stage II/III CRCs to establish the MSI status. The clinicopathologic differences and the prognostic value of MSI were analyzed. The median follow-up period was 38 months (range, 7-68 months). ResultsOf the total 245 patients, 20 (8.2%) had MSI-high (H) and 225 (91.8%) had MSI-low (L) or stable (S) CRCs. Adjuvant chemotherapies were performed on 101 stage II (87.8%) and 107 stage III patients (82.3%). Patients with MSI-H CRCs more frequently had a family history of colon cancer (10% vs. 2.7%, P = 0.003), more frequently had a cancer located at the proximal colon (90.0% vs. 19.1%, P < 0.0001), and more often showed a mucinous phenotype or poor differentiation (35.0% vs. 7.1%, P = 0.001). Despite less frequent lymph node metastasis (25% vs. 55.6%, P = 0.01), the number of retrieved lymph nodes was higher (26.3 ± 13.1 vs. 20.7 ± 1.2, P = 0.04) in the MSI-H group. The overall survival and the disease-free survival (DFS) did not differ with respect to MSI status. However, in the stage II subgroup, the DFS for patients with MSI-H CRCs was significantly worse (72.2% vs. 90.7%, P = 0.03). The multivariate analysis performed on this subgroup revealed that MSI-H was an independent poor prognostic factor (adjusted hazard ratio, 4.0; 95% confidence interval, 1.0-15.6, P = 0.046). ConclusionMSI-H CRCs had distinct clinicopathologic features, and MSI-H was an independent poor prognostic factor in stage II CRCs. Considering the majority of stage II patients were administrated adjuvant chemotherapy, the efficacy of adjuvant chemotherapy for treating MSI CRCs might be different from that for treating MSI-L/S tumors.
-
Citations
Citations to this article as recorded by 
- Incidence and Risk Factors of Parastomal Hernia
-
Yeun Ju Sohn, Sun Mi Moon, Ui Sup Shin, Sun Hee Jee
-
J Korean Soc Coloproctol. 2012;28(5):241-246. Published online October 31, 2012
-
DOI: https://doi.org/10.3393/jksc.2012.28.5.241
-
-
5,026
View
-
58
Download
-
55
Citations
-
Abstract
PDF
- Purpose
Among the various stoma complications, the parastomal hernia (PSH) is the most common. Prevention of PSH is very important to improve the quality of life and to prevent further serious complications. The aim of this study was to analyze the incidence and the risk factors of PSH. MethodsFrom January 2002 and October 2008, we retrospectively reviewed 165 patients who underwent an end colostomy. As a routine oncologic follow-up, abdomino-pelvic computed tomography was used to examine the occurrence of the PSH. The associations of age, sex, body mass index (BMI), history of steroid use and comorbidities to the development of the PSH were analyzed. The median duration of the follow-up was 36 months (0 to 99 months). ResultsDuring follow-up, 50 patients developed a PSH and the 5-year cumulative incidence rate of a PSH, obtained by using the Kaplan-Meier method, was 37.8%. In the multivariate COX analysis, female gender (hazard ratio [HR], 3.29; 95% confidence interval [CI], 1.77 to 6.11; P < 0.0001), age over 60 years (HR, 2.37; 95% CI, 1.26 to 4.46; P = 0.01), BMI more than 25 kg/m2 (HR, 1.8; 95% CI, 1.02 to 3.16; P = 0.04), and hypertension (HR, 2.08; 95% CI, 1.14 to 3.81; P = 0.02) were all independent risk factors for the development of a PSH. ConclusionThe 5-year incidence rate of a PSH was 37.8%. The significant risk factors of a PSH were as follows: female gender, age over 60 years, BMI more than 25 kg/m2, and hypertension. Using a prophylactic mesh during colostomy formation might be advisable when the patients have these factors.
-
Citations
Citations to this article as recorded by 
- Long-term outcomes after open parastomal hernia repair at a high-volume center
Alexis M. Holland, William R. Lorenz, Brittany S. Mead, Gregory T. Scarola, Vedra A. Augenstein, B. Todd Heniford, Monica E. Polcz Surgical Endoscopy.2025; 39(1): 639. CrossRef - Development and validation of a nomogram prediction model for the risk of parastomal hernia
Huasheng Liu, Weiqin Wang, Chen Qin, Hongxia Wang, Wei Qi, Yanhua Wei, Longbo Zheng, Jilin Hu Intelligent Medicine.2024; 4(2): 128. CrossRef - The clinical applications of D-type parastomal hernia repair surgery
Y. Y. Fu, Y. Ma, C. K. Zhang, L. H. Sun, D. Tang, W. Wang, D. R. Wang Hernia.2024; 28(2): 427. CrossRef - Comparison of the 3-D mesh and Sugarbaker repair for parastomal hernia: a single center experience in China
Hekai Shi, Shaochun Li, Yiming Lin, Dongchao Yang, Wenpei Dong, Zhicheng Song, Heng Song, Yan Gu Updates in Surgery.2024; 76(5): 1991. CrossRef - Evaluating EHS parastomal hernia classification for surgical planning: a retrospective analysis of 160 consecutive cases in a single center
Marek Szczepkowski, Mateusz Zamkowski, Suwała Alicja, Witkowski Piotr, Maciej Śmietański Hernia.2024; 28(5): 1915. CrossRef - Lap-re-Do Keyhole versus Lap-re-Do Sugarbaker techniques in large parastomal hernia repair: a retrospective cohort study
Xiaojian Fu, Minglei Li, Rong Hua, Qiyuan Yao Hernia.2024; 28(5): 1945. CrossRef - Risk factors for parastomal hernia after abdominoperineal resection of rectal cancer
Lele Zhu, Shun Li, Feitong Wang Frontiers in Oncology.2024;[Epub] CrossRef - Oncological outcome following Hartmann's procedure compared with anterior resection and abdominoperineal resection for rectal cancer—The type of procedure does not influence local recurrence or distant metastasis: A population‐based study
Dieter Hahnloser Colorectal Disease.2024; 26(10): 1794. CrossRef - A giant parastomal hernia in a high risk patient: preparation to make surgery worthwhile
Seda Gunes, Ali Bohlok, Antoine El Asmar, Thibaut Engels, Marie Magdelaine Lefort, Eleonora Farinella, Issam El Nakadi Acta Chirurgica Belgica.2023; 123(3): 309. CrossRef - Sugarbaker Versus Keyhole Repair for Parastomal Hernia: a Systematic Review and Meta-analysis of Comparative Studies
Andrew M. Fleming, Alisa L. Phillips, Justin A. Drake, Megan G. Gross, Danny Yakoub, Justin Monroe, Nathan M. Hinkle, David Shibata, Elizabeth H. Wood Journal of Gastrointestinal Surgery.2023; 27(3): 573. CrossRef - Contemporary Outcomes of Elective Parastomal Hernia Repair in Older Adults
Ryan Howard, Farizah Rob, Jyothi Thumma, Anne Ehlers, Sean O’Neill, Justin B. Dimick, Dana A. Telem JAMA Surgery.2023; 158(4): 394. CrossRef - The Risk Factors for Parastomal Hernia Development: A 8-year Retrospective Study in Colorectal Surgery
Tayfun BİŞGİN, Cahide AYİK, Deniz CENAN, Berke MANOĞLU, Dilek ÖZDEN, Selman SÖKMEN Journal of Basic and Clinical Health Sciences.2023; 7(2): 773. CrossRef - 67/w mit Vorwölbung um das Stoma
F. Köhler, Michael Meir Die Chirurgie.2023; 94(S1): 35. CrossRef - Effect of Obesity Classification on Complications after Sigmoidostomy for Low-Grade Rectal Cancer: A Retrospective Cohort Study
慧 王 Advances in Clinical Medicine.2023; 13(07): 11825. CrossRef - Risk Factors for the Development of Parastomal Hernia: A Narrative Review
Teodora Elena Manole, Ion Daniel, Bolocan Alexandra, Păduraru N. Dan, Octavian Andronic Saudi Journal of Medicine & Medical Sciences.2023; 11(3): 187. CrossRef - Modified Approach for Extraperitoneal Colostomy Creation in Laparoscopic Abdominoperineal Resection
Xiang Zhang, Xin Li, Zhiqiang Cheng, Kexin Wang, Yong Dai, Yanlei Wang Diseases of the Colon & Rectum.2023;[Epub] CrossRef - Prophylactic retromuscular mesh placement for parastomal hernia prevention: a retrospective cohort study of permanent colostomies and ileostomies
Jonathan Frigault, Simon Lemieux, Dominic Breton, Philippe Bouchard, Alexandre Bouchard, Roger C. Grégoire, François Letarte, Gilles Bouchard, Vincent Boun, Katia Massé, Sébastien Drolet Hernia.2022; 26(2): 495. CrossRef - Stoma creation is associated with a low incidence of midline incisional hernia after colorectal surgery: the “fighting over the fascia” theory concerning the incision and stoma hole
Noriaki Ohara, Kay Uehara, Atsushi Ogura, Masanori Sando, Toshisada Aiba, Yuki Murata, Takashi Mizuno, Kokuryo Toshio, Yukihiro Yokoyama, Satoko Ishigaki, Yuanying Li, Hiroshi Yatsuya, Tomoki Ebata Surgery Today.2022; 52(6): 953. CrossRef - Risk factors for the development of a parastomal hernia in patients with enterostomy: a systematic review and meta-analysis
Niu Niu, Shizheng Du, Dongliang Yang, Liuliu Zhang, Bainv Wu, Xiaoxu Zhi, Jun Li, Dejing Xu, Yinan Zhang, Aifeng Meng International Journal of Colorectal Disease.2022; 37(3): 507. CrossRef - An Analysis of the Risk Factors for the Development of Parastomal Hernia: A Single Institutional Experience
Faiza H Soomro, Sufyan Azam, Sritharan Ganeshmoorthy, Peter Waterland Cureus.2022;[Epub] CrossRef - Is absorbable mesh useful in preventing parastomal hernia after emergency surgery? The PARTHENOPE study
F. Pizza, D. D’Antonio, F. S. Lucido, P. Del Rio, C. Dell’Isola, L. Brusciano, S. Tolone, L. Docimo, C. Gambardella Hernia.2022; 26(2): 507. CrossRef - Comparison of the extraperitoneal and transperitoneal routes for permanent colostomy: a meta-analysis with RCTs and systematic review
Jinlong Luo, Dujanand Singh, Faqiang Zhang, Xinting Yang, Xiaoying Zha, Huaiwu Jiang, Lie Yang, Hua Yang World Journal of Surgical Oncology.2022;[Epub] CrossRef - Bariatric Surgery in Patients with Existing Ostomy: A Preliminary Feasibility Study
Ray Portela, Ahmet Vahibe, Joseph N. Badaoui, Omer U.I. Hassan, Travis J. Mckenzie, Todd A. Kellogg, Omar M. Ghanem Bariatric Surgical Practice and Patient Care.2022; 17(2): 127. CrossRef - Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy
S. Täckström, A. Chabok, K. Smedh, M. Nikberg Hernia.2022; 26(2): 517. CrossRef - Incidence and risk factors for parastomal hernia with a permanent colostomy
Lei Liu, Longbo Zheng, Maoshen Zhang, Jilin Hu, Yun Lu, Dongsheng Wang Journal of Surgical Oncology.2022; 126(3): 535. CrossRef - Obesity Stratification Predicts Short-Term Complications After Parastomal Hernia Repair
Mustafa Tamim Alam Khan, Ronit Patnaik, Lee Hausman-Cohen, Olivia Panchal, Mackenzie Ewart, Rehana Sultana Lovely, Aashish Rajesh Journal of Surgical Research.2022; 280: 27. CrossRef - Stoma-Related Complications: A Single-Center Experience and Literature Review
Zalán Benedek, Loránd Kocsis, Orsolya Bauer, Nicolae Suciu, Sorin Sorlea, Călin Crăciun, Rareș Georgescu, Marius Florin Coroș Journal of Interdisciplinary Medicine.2022; 7(2): 31. CrossRef - Permanent end-colostomy parastomal hernia prevention using a novel three-dimensional mesh
Camillo Leonardo Bertoglio, Marianna Maspero, Lorenzo Morini, Andrea Zironda, Bruno Domenico Alampi, Michele Mazzola, Carmelo Magistro, Pietro Carnevali, Giovanni Ferrari Hernia.2021; 25(3): 655. CrossRef - Risk Factors for Parastomal Hernia Associated with Covering Stoma in Rectal Surgery
Kazuhiro Ishimaru, Yasutaka Shuno, Hiroaki Nozawa, Kazushige Kawai, Koji Murono, Soichiro Ishihara Indian Journal of Surgery.2021; 83(S3): 749. CrossRef - The role of radiological classification of parastomal hernia as a predictor of the need for surgical hernia repair: a retrospective cohort study
Jonathan Frigault, Simon Lemieux, Dominic Breton, Gilles Bouchard, Sébastien Drolet Langenbeck's Archives of Surgery.2021; 406(5): 1643. CrossRef - Short-term outcomes of laparoscopic Sugarbaker repair of
parastomal hernia
Hữu Thịnh Nguyễn, Ngọc Trường Vinh Nguyễn Vietnam Journal of Endolaparoscopic Surgery.2021;[Epub] CrossRef - Use of prophylactic mesh during initial stoma creation to prevent parastomal herniation: a systematic review and meta‐analysis of randomised controlled trials
Syed Mohiuddin, William Hollingworth, Niroshini Rajaretnam, Barnaby C. Reeves, Neil J. Smart Colorectal Disease.2021; 23(11): 2821. CrossRef - A semi‐Markov model comparing the lifetime cost‐effectiveness of mesh prophylaxis to prevent parastomal hernia in patients undergoing end colostomy creation for rectal cancer
Syed Mohiuddin, Barnaby C. Reeves, Neil J. Smart, William Hollingworth Colorectal Disease.2021; 23(11): 2967. CrossRef - Abdominal Oblique Internal and External Muscles Gap Colostomy for Lower Incidence of Parastomal Hernia and Higher Quality of Life: A Retrospective Cohort Study
Yongjian Huang, Hengkai Chen, Qiajun Zheng, Xiaohan Lin, Guangwei Zhu, Jinzhou Wang, Changli Huang, Jianxin Ye World Journal of Surgery.2021; 45(12): 3623. CrossRef - Patient-Related Factors Associated With Stoma and Peristomal Complications Following Fecal Ostomy Surgery
Piotr Zelga, Piotr Kluska, Marta Zelga, Joanna Piasecka-Zelga, Adam Dziki Journal of Wound, Ostomy & Continence Nursing.2021; 48(5): 415. CrossRef - Comparison of different modalities for the diagnosis of parastomal hernia: a systematic review
Gijs H. J. de Smet, Daniël P. V. Lambrichts, Sjoerd van den Hoek, Leonard F. Kroese, Stefan Buettner, Anand G. Menon, Gert-Jan Kleinrensink, Johan F. Lange International Journal of Colorectal Disease.2020; 35(2): 199. CrossRef - Stoma-Related Complications Following Ostomy Surgery in 3 Acute Care Hospitals
Robert Pearson, Stephen R. Knight, James C. K. Ng, Isabell Robertson, Clare McKenzie, Angus M. Macdonald Journal of Wound, Ostomy & Continence Nursing.2020; 47(1): 32. CrossRef - Stomach in a parastomal hernia: a rare complication of stomas
Onyekachi Ezekiel Ekowo, Ammar Al Midani, Yasser Abdulaal, Mohamed Boshnaq BMJ Case Reports.2020; 13(8): e234325. CrossRef - Parastomal Hernia Following Abdominoperineal Resection
Alimohammad Bananzadeh, Ibrahim Jaweek, Mohammad Rezazadehkermani, Leila Ghahramani, Faranak Bahrami, Seyed Vahid Hosseini, Ahmad Izadpanah, Seyed Mohammad Kazem Tadayon Journal of Coloproctology.2020; 40(04): 311. CrossRef - Radiological progression of end colostomy trephine diameter and area
K. K. Ho, T. Economou, N. J. Smart, I. R. Daniels BJS Open.2019; 3(1): 112. CrossRef - Colostomy on CT and fluoroscopy: What the radiologist needs to know
Shari Friedman, Zina J. Ricci, Marjorie W. Stein, Ellen L. Wolf, Tulay Ekinci, Fernanda S. Mazzariol, Mariya Kobi Clinical Imaging.2019; 56: 17. CrossRef - Parastomal hernias causing symptoms or requiring surgical repair after colorectal cancer surgery—a national population-based cohort study
Mathilda Tivenius, Pia Näsvall, Gabriel Sandblom International Journal of Colorectal Disease.2019; 34(7): 1267. CrossRef - Prevention of parastomal hernia after abdominoperineal excision with a prophylactic three‐dimensional funnel mesh
J. López‐Borao, Z. Madrazo‐González, E. Kreisler, S. Biondo Colorectal Disease.2019; 21(11): 1326. CrossRef - Parastomal Hernia Repair Outcomes: A Nine-Year Experience
You Wei Lin, Patrick Keller, Daniel L. Davenport, Margaret A. Plymale, Crystal F. Totten, John Scott Roth The American Surgeon™.2019; 85(7): 738. CrossRef - European Hernia Society guidelines on prevention and treatment of parastomal hernias
S. A. Antoniou, F. Agresta, J. M. Garcia Alamino, D. Berger, F. Berrevoet, H.-T. Brandsma, K. Bury, J. Conze, D. Cuccurullo, U. A. Dietz, R. H. Fortelny, C. Frei-Lanter, B. Hansson, F. Helgstrand, A. Hotouras, A. Jänes, L. F. Kroese, J. R. Lambrecht, I. K Hernia.2018; 22(1): 183. CrossRef - Incidence and risk factors for parastomal bulging in patients with ileostomy or colostomy: a register‐based study using data from the Danish Stoma Database Capital Region
R. M. Andersen, T. W. Klausen, A. K. Danielsen, A. Vinther, I. Gögenur, T. Thomsen Colorectal Disease.2018; 20(4): 331. CrossRef - Relationship between stoma creation route for end colostomy and parastomal hernia development after laparoscopic surgery
Hitoshi Hino, Tomohiro Yamaguchi, Yusuke Kinugasa, Akio Shiomi, Hiroyasu Kagawa, Yushi Yamakawa, Masakatsu Numata, Akinobu Furutani, Takuya Suzuki, Kakeru Torii Surgical Endoscopy.2017; 31(4): 1966. CrossRef - Prophylactic mesh to prevent parastomal hernia after end colostomy: a meta-analysis and trial sequential analysis
M. López-Cano, H.-T. Brandsma, K. Bury, B. Hansson, I. Kyle-Leinhase, J. G. Alamino, F. Muysoms Hernia.2017; 21(2): 177. CrossRef - Laparoscopic prosthetic parastomal and perineal hernia repair after abdominoperineal resection
G. Dapri, L. Gerard, L. Cardinali, D. Repullo, I. Surdeanu, S. H. Sondji, G.-B. Cadière, S. Saussez Techniques in Coloproctology.2017; 21(1): 73. CrossRef - Predictors of quality-of-life after ileal pouch-anal anastomosis in patients with ulcerative colitis
Sherif Abolfotouh, Tero Rautio, Kai Klintrup, Ilona Helavirta, Jyrki Mäkelä Scandinavian Journal of Gastroenterology.2017; 52(10): 1078. CrossRef - An Evaluation of Parastomal Hernia Repair Using the Americas Hernia Society Quality Collaborative
Sarah S. Fox, Randy Janczyk, Jeremy A. Warren, Alfredo M. Carbonell, Benjamin K. Poulose, Michael J. Rosen, William W. Hope The American Surgeon™.2017; 83(8): 881. CrossRef - Parastomal hernias after radical cystectomy and ileal conduit diversion
Timothy F. Donahue, Bernard H. Bochner Investigative and Clinical Urology.2016; 57(4): 240. CrossRef - Parastomal Hernia Containing Stomach
Sebastian Barber-Millet, Salvador Pous, Vicente Navarro, Jose Iserte, Eduardo García-Granero International Surgery.2014; 99(4): 404. CrossRef - Paracolostomy Hernia Repair: Who and When?
Zachary A. Gregg, Haisar E. Dao, Steven Schechter, Nishit Shah Journal of the American College of Surgeons.2014; 218(6): 1105. CrossRef - Risk factors for parastomal hernia in Japanese patients with permanent colostomy
Kimihiko Funahashi, Takayuki Suzuki, Yasuo Nagashima, Satoshi Matsuda, Junichi Koike, Hiroyuki Shiokawa, Mitsunori Ushigome, Kenichiro Arai, Tomoaki Kaneko, Akiharu Kurihara, Hironori Kaneko Surgery Today.2014; 44(8): 1465. CrossRef
- Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
-
Sun Hee Jee, Sun Mi Moon, Ui Sup Shin, Hoe Min Yang, Dae-Yong Hwang
-
J Korean Soc Coloproctol. 2011;27(6):322-328. Published online December 31, 2011
-
DOI: https://doi.org/10.3393/jksc.2011.27.6.322
-
-
4,516
View
-
36
Download
-
17
Citations
-
Abstract
PDF
- Purpose
The aims of this study were to investigate the survival results and the prognostic factors of adjuvant chemotherapy in stage II colon cancer in the sparsity of Korean data. MethodsFrom 1993 to 2006, 363 curatively resected pathologic stage II colon cancer patients were enrolled. Six cycles of adjuvant chemotherapy was performed: intravenous bolus 5-fluorouracil (5-FU) 500 mg/m2 with leucovorin 20 mg/m2 for 2 hours daily for 5 days, followed by a 3-week resting period (n = 308). Fifty-five patients received only curative surgery. A high risk of recurrence was defined as the presence of one or more of the following factors: T4 tumor, lympho-vascular invasion, perineural invasion, perforation, obstruction, retrieved lymph node < 12, and poorly differention. The median follow-up period was 68 months (1 to 205 months). ResultsThe five-year overall survival (OS) rate was 90.1%, and the five-year disease-free survival (DFS) rate was 84.7%. Among high-risk patients, the OS and the DFS rates of the treatment group were significantly higher than those of the non-treatment group (OS: 90.6% vs. 69.1%, P < 0.0001; DFS: 85.9% vs. 54.1%, P < 0.0001). Among low-risk patients, the survival results of the treatment group were also significantly superior (OS: 97.7% vs. 88.2%, P < 0.0001; DFS: 93.0% vs. 80.0%, P = 0.001). In the multivariate analysis, adjuvant chemotherapy was a significantly favorable prognostic factor for overall survival (hazard ratio, 0.41; 95% confidence interval, 0.22 to 0.75; P = 0.004). ConclusionIn our population, adjuvant chemotherapy showed superior survival to curative surgery alone and significantly reduced the risk of death. A nationwide multicenter randomized trial is needed.
-
Citations
Citations to this article as recorded by 
- Novel Drug Combinations in Lung Cancer: New Potential Synergies Between 5-FU and Repurposed Drugs
Eduarda Ribeiro, Nuno Vale Applied Sciences.2024; 14(21): 9658. CrossRef - Ulva pertusa Modulated Colonic Oxidative Stress Markers and Clinical Parameters: A Potential Adjuvant Therapy to Manage Side Effects During 5-FU Regimen
Alberto Repici, Anna Paola Capra, Ahmed Hasan, Rossella Basilotta, Sarah Adriana Scuderi, Michela Campolo, Irene Paterniti, Emanuela Esposito, Alessio Ardizzone International Journal of Molecular Sciences.2024; 25(23): 12988. CrossRef - Using zebrafish to assess the effect of chronic, early developmental exposure to environmentally relevant concentrations of 5-fluorouracil and leucovorin
M. Ng, K. DeCicco-Skinner, V.P. Connaughton Environmental Toxicology and Pharmacology.2020; 76: 103356. CrossRef - Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis
C. Simillis, H. K. S. I. Singh, T. Afxentiou, S. Mills, O. J. Warren, J. J. Smith, P. Riddle, M. Adamina, D. Cunningham, P. P. Tekkis Colorectal Disease.2020; 22(10): 1231. CrossRef - Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
Chao Zhang, Songcheng Yin, Yuen Tan, Jinyu Huang, Pengliang Wang, Wenbin Hou, Zhe Zhang, Huimian Xu American Journal of Clinical Oncology.2020; 43(4): 279. CrossRef - Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells
Jiaxun Tian, Jiamei Mo, Lan Xu, Rui Zhang, Yun Qiao, Bin Liu, Lei Jiang, Siyang Ma, Gang Shi Chemico-Biological Interactions.2020; 327: 109184. CrossRef - Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer
Yusuke Okuda, Takaya Shimura, Tomonori Yamada, Yoshikazu Hirata, Ryuzo Yamaguchi, Eiji Sakamoto, Hiromi Kataoka International Journal of Clinical Oncology.2018; 23(6): 1101. CrossRef - Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data
Min Ki Kim, Daeyoun David Won, Sun Min Park, Taejung Kim, Sung Ryong Kim, Seong Taek Oh, Seung Kook Sohn, Mi Yeon Kang, In Kyu Lee Cancer Research and Treatment.2018; 50(4): 1149. CrossRef - Perineural Invasion Is a Strong Prognostic Factor in Colorectal Cancer
Nikki Knijn, Stephanie C. Mogk, Steven Teerenstra, Femke Simmer, Iris D. Nagtegaal American Journal of Surgical Pathology.2016; 40(1): 103. CrossRef - Prognostic Value of Perineural Invasion in Colorectal Cancer: A Meta-Analysis
Yuchong Yang, Xuanzhang Huang, Jingxu Sun, Peng Gao, Yongxi Song, Xiaowan Chen, Junhua Zhao, Zhenning Wang Journal of Gastrointestinal Surgery.2015; 19(6): 1113. CrossRef - Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways
ZHEN HUANG, YE XU, WEI PENG Molecular Medicine Reports.2015; 12(4): 5939. CrossRef - Is Microsatellite Instability Really a Good Prognostic Factor of Colorectal Cancer?
Ui Sup Shin, Sang Sik Cho, Sun Mi Moon, Sun Hoo Park, Sun Hee Jee, Eun-Joo Jung, Dae-Yong Hwang Annals of Coloproctology.2014; 30(1): 28. CrossRef - The Sirtuin 3 Expression Profile Is Associated with Pathological and Clinical Outcomes in Colon Cancer Patients
Chunyuan Liu, Zonghai Huang, Hong Jiang, Fujun Shi BioMed Research International.2014; 2014: 1. CrossRef - Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study
Mehmet Artac, Nazim Serdar Turhal, Murat Kocer, Bulent Karabulut, Hakan Bozcuk, Suayip Yalcin, Mustafa Karaagac, Seyda Gündüz, Nalan Isik, Kazim Uygun Tumori Journal.2014; 100(2): 143. CrossRef - Laparoscopic Colectomy Decreases the Time to Administration of Chemotherapy Compared with Open Colectomy
Vitaliy Poylin, Thomas Curran, Eliza Lee, Deborah Nagle Annals of Surgical Oncology.2014; 21(11): 3587. CrossRef - Identification of the Risk Factors for Recurrence of Stage II Rectal Cancer
Sho Sawazaki, Manabu Shiozawa, Teni Godai, Yusuke Katayama, Koji Numata, Akio Higuchi, Yasushi Rino, Munetaka Masuda, Makoto Akaike Nippon Daicho Komonbyo Gakkai Zasshi.2014; 67(5): 305. CrossRef - Current Controversies in the Management of Colon Cancer
Supriya S. Patel, Adrienne Floyd, Michael G. Doorly, Adrian E. Ortega, Glenn T. Ault, Andreas M. Kaiser, Anthony J. Senagore Current Problems in Surgery.2012; 49(7): 398. CrossRef
|